nodes	percent_of_prediction	percent_of_DWPC	metapath
Vismodegib—ABCG2—epilepsy syndrome	0.118	0.379	CbGaD
Vismodegib—CYP2C19—epilepsy syndrome	0.0931	0.298	CbGaD
Vismodegib—ALB—epilepsy syndrome	0.0517	0.165	CbGaD
Vismodegib—ABCB1—epilepsy syndrome	0.0493	0.158	CbGaD
Vismodegib—ALB—Oxcarbazepine—epilepsy syndrome	0.019	0.0414	CbGbCtD
Vismodegib—ALB—Fosphenytoin—epilepsy syndrome	0.0166	0.0362	CbGbCtD
Vismodegib—ALB—Clonazepam—epilepsy syndrome	0.015	0.0327	CbGbCtD
Vismodegib—CYP2C8—Trimethadione—epilepsy syndrome	0.0136	0.0298	CbGbCtD
Vismodegib—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0128	0.028	CbGbCtD
Vismodegib—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0123	0.0268	CbGbCtD
Vismodegib—ALB—Rufinamide—epilepsy syndrome	0.0122	0.0267	CbGbCtD
Vismodegib—CYP2C19—Felbamate—epilepsy syndrome	0.0114	0.025	CbGbCtD
Vismodegib—CYP2C19—Trimethadione—epilepsy syndrome	0.0114	0.025	CbGbCtD
Vismodegib—ABCB1—Levetiracetam—epilepsy syndrome	0.0108	0.0237	CbGbCtD
Vismodegib—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0107	0.0235	CbGbCtD
Vismodegib—ALB—Phenytoin—epilepsy syndrome	0.0107	0.0233	CbGbCtD
Vismodegib—ALB—Propofol—epilepsy syndrome	0.00996	0.0218	CbGbCtD
Vismodegib—CYP2C9—Trimethadione—epilepsy syndrome	0.0095	0.0208	CbGbCtD
Vismodegib—CYP2C19—Clobazam—epilepsy syndrome	0.00931	0.0203	CbGbCtD
Vismodegib—CYP2C8—Carbamazepine—epilepsy syndrome	0.0092	0.0201	CbGbCtD
Vismodegib—ALB—Diazepam—epilepsy syndrome	0.00902	0.0197	CbGbCtD
Vismodegib—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00893	0.0195	CbGbCtD
Vismodegib—CYP2C8—Primidone—epilepsy syndrome	0.00859	0.0188	CbGbCtD
Vismodegib—CYP2C8—Phenytoin—epilepsy syndrome	0.00825	0.018	CbGbCtD
Vismodegib—SHH—skull—epilepsy syndrome	0.00808	0.171	CbGeAlD
Vismodegib—SHH—forelimb—epilepsy syndrome	0.00778	0.165	CbGeAlD
Vismodegib—CYP2C19—Carbamazepine—epilepsy syndrome	0.00772	0.0169	CbGbCtD
Vismodegib—CYP2C8—Propofol—epilepsy syndrome	0.00769	0.0168	CbGbCtD
Vismodegib—ABCB1—Clobazam—epilepsy syndrome	0.00751	0.0164	CbGbCtD
Vismodegib—CYP2C8—Phenobarbital—epilepsy syndrome	0.00735	0.0161	CbGbCtD
Vismodegib—ABCB1—Lamotrigine—epilepsy syndrome	0.00723	0.0158	CbGbCtD
Vismodegib—CYP2C19—Primidone—epilepsy syndrome	0.0072	0.0157	CbGbCtD
Vismodegib—CYP2C8—Diazepam—epilepsy syndrome	0.00697	0.0152	CbGbCtD
Vismodegib—CYP2C19—Phenytoin—epilepsy syndrome	0.00692	0.0151	CbGbCtD
Vismodegib—SHH—telencephalic ventricle—epilepsy syndrome	0.00676	0.143	CbGeAlD
Vismodegib—CYP2C19—Propofol—epilepsy syndrome	0.00645	0.0141	CbGbCtD
Vismodegib—CYP2C9—Carbamazepine—epilepsy syndrome	0.00641	0.014	CbGbCtD
Vismodegib—ABCB1—Carbamazepine—epilepsy syndrome	0.00623	0.0136	CbGbCtD
Vismodegib—CYP2C19—Phenobarbital—epilepsy syndrome	0.00617	0.0135	CbGbCtD
Vismodegib—CYP2C9—Primidone—epilepsy syndrome	0.00599	0.0131	CbGbCtD
Vismodegib—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00594	0.013	CbGbCtD
Vismodegib—CYP2C19—Diazepam—epilepsy syndrome	0.00585	0.0128	CbGbCtD
Vismodegib—CYP2C9—Phenytoin—epilepsy syndrome	0.00575	0.0126	CbGbCtD
Vismodegib—CYP2C19—Zonisamide—epilepsy syndrome	0.00571	0.0125	CbGbCtD
Vismodegib—ABCB1—Phenytoin—epilepsy syndrome	0.00558	0.0122	CbGbCtD
Vismodegib—CYP3A4—Felbamate—epilepsy syndrome	0.00552	0.0121	CbGbCtD
Vismodegib—CYP3A4—Trimethadione—epilepsy syndrome	0.00552	0.0121	CbGbCtD
Vismodegib—CYP2C8—Valproic Acid—epilepsy syndrome	0.00549	0.012	CbGbCtD
Vismodegib—CYP2C9—Propofol—epilepsy syndrome	0.00537	0.0117	CbGbCtD
Vismodegib—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00519	0.0113	CbGbCtD
Vismodegib—CYP2C9—Phenobarbital—epilepsy syndrome	0.00513	0.0112	CbGbCtD
Vismodegib—ABCB1—Phenobarbital—epilepsy syndrome	0.00498	0.0109	CbGbCtD
Vismodegib—ABCB1—Midazolam—epilepsy syndrome	0.00491	0.0107	CbGbCtD
Vismodegib—CYP2C9—Diazepam—epilepsy syndrome	0.00486	0.0106	CbGbCtD
Vismodegib—ABCB1—Diazepam—epilepsy syndrome	0.00472	0.0103	CbGbCtD
Vismodegib—CYP3A4—Clonazepam—epilepsy syndrome	0.0047	0.0103	CbGbCtD
Vismodegib—CYP2C19—Valproic Acid—epilepsy syndrome	0.00461	0.0101	CbGbCtD
Vismodegib—CYP3A4—Clobazam—epilepsy syndrome	0.0045	0.00984	CbGbCtD
Vismodegib—CYP2C19—Topiramate—epilepsy syndrome	0.00416	0.00909	CbGbCtD
Vismodegib—CYP2C9—Valproic Acid—epilepsy syndrome	0.00383	0.00837	CbGbCtD
Vismodegib—CYP3A4—Rufinamide—epilepsy syndrome	0.00383	0.00836	CbGbCtD
Vismodegib—CYP3A4—Carbamazepine—epilepsy syndrome	0.00373	0.00815	CbGbCtD
Vismodegib—CYP3A4—Primidone—epilepsy syndrome	0.00348	0.00761	CbGbCtD
Vismodegib—CYP3A4—Phenytoin—epilepsy syndrome	0.00335	0.00731	CbGbCtD
Vismodegib—SHH—hindbrain—epilepsy syndrome	0.00319	0.0674	CbGeAlD
Vismodegib—CYP3A4—Propofol—epilepsy syndrome	0.00312	0.00682	CbGbCtD
Vismodegib—CYP3A4—Acetazolamide—epilepsy syndrome	0.00298	0.00652	CbGbCtD
Vismodegib—CYP3A4—Phenobarbital—epilepsy syndrome	0.00298	0.00652	CbGbCtD
Vismodegib—CYP3A4—Midazolam—epilepsy syndrome	0.00294	0.00643	CbGbCtD
Vismodegib—CYP3A4—Diazepam—epilepsy syndrome	0.00283	0.00618	CbGbCtD
Vismodegib—CYP3A4—Zonisamide—epilepsy syndrome	0.00276	0.00603	CbGbCtD
Vismodegib—CYP3A4—Valproic Acid—epilepsy syndrome	0.00223	0.00487	CbGbCtD
Vismodegib—CYP3A4—Topiramate—epilepsy syndrome	0.00201	0.00439	CbGbCtD
Vismodegib—SHH—brainstem—epilepsy syndrome	0.00183	0.0386	CbGeAlD
Vismodegib—SHH—forebrain—epilepsy syndrome	0.00176	0.0373	CbGeAlD
Vismodegib—SHH—telencephalon—epilepsy syndrome	0.00162	0.0343	CbGeAlD
Vismodegib—SHH—midbrain—epilepsy syndrome	0.00117	0.0246	CbGeAlD
Vismodegib—SHH—spinal cord—epilepsy syndrome	0.00114	0.024	CbGeAlD
Vismodegib—SHH—head—epilepsy syndrome	0.00101	0.0214	CbGeAlD
Vismodegib—SHH—nervous system—epilepsy syndrome	0.000958	0.0202	CbGeAlD
Vismodegib—SHH—central nervous system—epilepsy syndrome	0.000922	0.0195	CbGeAlD
Vismodegib—SHH—cerebellum—epilepsy syndrome	0.000901	0.0191	CbGeAlD
Vismodegib—SMO—medulla oblongata—epilepsy syndrome	0.000892	0.0188	CbGeAlD
Vismodegib—SMO—midbrain—epilepsy syndrome	0.000815	0.0172	CbGeAlD
Vismodegib—SMO—spinal cord—epilepsy syndrome	0.000795	0.0168	CbGeAlD
Vismodegib—SHH—brain—epilepsy syndrome	0.000732	0.0155	CbGeAlD
Vismodegib—SMO—head—epilepsy syndrome	0.000707	0.0149	CbGeAlD
Vismodegib—Sorafenib—RET—epilepsy syndrome	0.00069	0.22	CrCbGaD
Vismodegib—SMO—nervous system—epilepsy syndrome	0.00067	0.0142	CbGeAlD
Vismodegib—SMO—central nervous system—epilepsy syndrome	0.000645	0.0136	CbGeAlD
Vismodegib—SMO—cerebellum—epilepsy syndrome	0.00063	0.0133	CbGeAlD
Vismodegib—SMO—brain—epilepsy syndrome	0.000512	0.0108	CbGeAlD
Vismodegib—Sorafenib—KDR—epilepsy syndrome	0.000363	0.115	CrCbGaD
Vismodegib—ORM1—spinal cord—epilepsy syndrome	0.000347	0.00734	CbGeAlD
Vismodegib—ABCG2—telencephalon—epilepsy syndrome	0.000297	0.00628	CbGeAlD
Vismodegib—ORM1—nervous system—epilepsy syndrome	0.000293	0.00619	CbGeAlD
Vismodegib—ORM1—central nervous system—epilepsy syndrome	0.000282	0.00596	CbGeAlD
Vismodegib—Etoricoxib—CYP2C19—epilepsy syndrome	0.000268	0.0853	CrCbGaD
Vismodegib—ABCG2—medulla oblongata—epilepsy syndrome	0.000233	0.00494	CbGeAlD
Vismodegib—Sulfasalazine—ABCC2—epilepsy syndrome	0.000227	0.0723	CrCbGaD
Vismodegib—Sorafenib—ABCC2—epilepsy syndrome	0.000214	0.0683	CrCbGaD
Vismodegib—ABCG2—midbrain—epilepsy syndrome	0.000213	0.00451	CbGeAlD
Vismodegib—ABCG2—spinal cord—epilepsy syndrome	0.000208	0.0044	CbGeAlD
Vismodegib—Sulfasalazine—ABCG2—epilepsy syndrome	0.000201	0.0639	CrCbGaD
Vismodegib—Etoricoxib—CYP2D6—epilepsy syndrome	0.000198	0.0632	CrCbGaD
Vismodegib—ALB—brain—epilepsy syndrome	0.000196	0.00415	CbGeAlD
Vismodegib—Sorafenib—ABCG2—epilepsy syndrome	0.000189	0.0603	CrCbGaD
Vismodegib—Tolvaptan—ABCB1—epilepsy syndrome	0.000187	0.0596	CrCbGaD
Vismodegib—Etoricoxib—PTGS2—epilepsy syndrome	0.000167	0.0531	CrCbGaD
Vismodegib—ABCG2—cerebellum—epilepsy syndrome	0.000165	0.00349	CbGeAlD
Vismodegib—ABCB1—forebrain—epilepsy syndrome	0.000159	0.00337	CbGeAlD
Vismodegib—Sorafenib—CYP2C19—epilepsy syndrome	0.000149	0.0474	CrCbGaD
Vismodegib—ABCB1—telencephalon—epilepsy syndrome	0.000147	0.0031	CbGeAlD
Vismodegib—CYP2C8—brain—epilepsy syndrome	0.000138	0.00292	CbGeAlD
Vismodegib—ABCG2—brain—epilepsy syndrome	0.000134	0.00283	CbGeAlD
Vismodegib—Diarrhoea—Acetazolamide—epilepsy syndrome	0.000132	0.00123	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Oxcarbazepine—epilepsy syndrome	0.000132	0.00122	CcSEcCtD
Vismodegib—Nervous system disorder—Lamotrigine—epilepsy syndrome	0.000132	0.00122	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	0.000132	0.00122	CcSEcCtD
Vismodegib—Gastrointestinal pain—Diazepam—epilepsy syndrome	0.000132	0.00122	CcSEcCtD
Vismodegib—Fatigue—Zonisamide—epilepsy syndrome	0.000131	0.00122	CcSEcCtD
Vismodegib—Malnutrition—Valproic Acid—epilepsy syndrome	0.000131	0.00121	CcSEcCtD
Vismodegib—Constipation—Zonisamide—epilepsy syndrome	0.00013	0.00121	CcSEcCtD
Vismodegib—Dyspepsia—Clonazepam—epilepsy syndrome	0.000129	0.0012	CcSEcCtD
Vismodegib—Abdominal pain—Vigabatrin—epilepsy syndrome	0.000129	0.0012	CcSEcCtD
Vismodegib—Nausea—Clobazam—epilepsy syndrome	0.000129	0.00119	CcSEcCtD
Vismodegib—Asthenia—Propofol—epilepsy syndrome	0.000129	0.00119	CcSEcCtD
Vismodegib—Dyspepsia—Phenytoin—epilepsy syndrome	0.000128	0.00119	CcSEcCtD
Vismodegib—Dysgeusia—Valproic Acid—epilepsy syndrome	0.000128	0.00119	CcSEcCtD
Vismodegib—Dyspepsia—Oxcarbazepine—epilepsy syndrome	0.000128	0.00118	CcSEcCtD
Vismodegib—Decreased appetite—Clonazepam—epilepsy syndrome	0.000128	0.00118	CcSEcCtD
Vismodegib—Gastrointestinal pain—Felbamate—epilepsy syndrome	0.000127	0.00118	CcSEcCtD
Vismodegib—Pruritus—Propofol—epilepsy syndrome	0.000127	0.00118	CcSEcCtD
Vismodegib—Abdominal pain—Diazepam—epilepsy syndrome	0.000127	0.00118	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Carbamazepine—epilepsy syndrome	0.000127	0.00117	CcSEcCtD
Vismodegib—Decreased appetite—Phenytoin—epilepsy syndrome	0.000127	0.00117	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.000127	0.00117	CcSEcCtD
Vismodegib—Back pain—Valproic Acid—epilepsy syndrome	0.000127	0.00117	CcSEcCtD
Vismodegib—Fatigue—Clonazepam—epilepsy syndrome	0.000127	0.00117	CcSEcCtD
Vismodegib—Asthenia—Midazolam—epilepsy syndrome	0.000126	0.00117	CcSEcCtD
Vismodegib—Decreased appetite—Oxcarbazepine—epilepsy syndrome	0.000126	0.00117	CcSEcCtD
Vismodegib—Muscle spasms—Valproic Acid—epilepsy syndrome	0.000126	0.00117	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.000126	0.00117	CcSEcCtD
Vismodegib—Fatigue—Phenytoin—epilepsy syndrome	0.000126	0.00116	CcSEcCtD
Vismodegib—Pain—Clonazepam—epilepsy syndrome	0.000126	0.00116	CcSEcCtD
Vismodegib—Constipation—Clonazepam—epilepsy syndrome	0.000126	0.00116	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.000125	0.00116	CcSEcCtD
Vismodegib—Fatigue—Oxcarbazepine—epilepsy syndrome	0.000125	0.00116	CcSEcCtD
Vismodegib—Constipation—Phenytoin—epilepsy syndrome	0.000125	0.00116	CcSEcCtD
Vismodegib—Gastrointestinal pain—Zonisamide—epilepsy syndrome	0.000125	0.00115	CcSEcCtD
Vismodegib—Asthenia—Levetiracetam—epilepsy syndrome	0.000125	0.00115	CcSEcCtD
Vismodegib—Pruritus—Midazolam—epilepsy syndrome	0.000124	0.00115	CcSEcCtD
Vismodegib—Pain—Oxcarbazepine—epilepsy syndrome	0.000124	0.00115	CcSEcCtD
Vismodegib—Constipation—Oxcarbazepine—epilepsy syndrome	0.000124	0.00115	CcSEcCtD
Vismodegib—Abdominal pain—Felbamate—epilepsy syndrome	0.000123	0.00114	CcSEcCtD
Vismodegib—Vomiting—Acetazolamide—epilepsy syndrome	0.000123	0.00114	CcSEcCtD
Vismodegib—Diarrhoea—Propofol—epilepsy syndrome	0.000123	0.00114	CcSEcCtD
Vismodegib—Pruritus—Levetiracetam—epilepsy syndrome	0.000123	0.00114	CcSEcCtD
Vismodegib—Connective tissue disorder—Gabapentin—epilepsy syndrome	0.000123	0.00114	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	0.000123	0.00114	CcSEcCtD
Vismodegib—Dyspepsia—Carbamazepine—epilepsy syndrome	0.000123	0.00113	CcSEcCtD
Vismodegib—CYP3A4—nervous system—epilepsy syndrome	0.000122	0.00258	CbGeAlD
Vismodegib—Decreased appetite—Carbamazepine—epilepsy syndrome	0.000121	0.00112	CcSEcCtD
Vismodegib—Abdominal pain—Zonisamide—epilepsy syndrome	0.000121	0.00112	CcSEcCtD
Vismodegib—Asthenia—Fosphenytoin—epilepsy syndrome	0.00012	0.00111	CcSEcCtD
Vismodegib—Alopecia—Pregabalin—epilepsy syndrome	0.00012	0.00111	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.00012	0.00111	CcSEcCtD
Vismodegib—Gastrointestinal pain—Clonazepam—epilepsy syndrome	0.00012	0.00111	CcSEcCtD
Vismodegib—Fatigue—Carbamazepine—epilepsy syndrome	0.00012	0.00111	CcSEcCtD
Vismodegib—Constipation—Carbamazepine—epilepsy syndrome	0.000119	0.0011	CcSEcCtD
Vismodegib—Pain—Carbamazepine—epilepsy syndrome	0.000119	0.0011	CcSEcCtD
Vismodegib—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000119	0.0011	CcSEcCtD
Vismodegib—Weight decreased—Topiramate—epilepsy syndrome	0.000119	0.0011	CcSEcCtD
Vismodegib—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.000119	0.0011	CcSEcCtD
Vismodegib—Pruritus—Fosphenytoin—epilepsy syndrome	0.000119	0.0011	CcSEcCtD
Vismodegib—Dyspepsia—Lamotrigine—epilepsy syndrome	0.000119	0.0011	CcSEcCtD
Vismodegib—Malnutrition—Pregabalin—epilepsy syndrome	0.000119	0.0011	CcSEcCtD
Vismodegib—CYP3A4—central nervous system—epilepsy syndrome	0.000118	0.00249	CbGeAlD
Vismodegib—Asthenia—Vigabatrin—epilepsy syndrome	0.000117	0.00109	CcSEcCtD
Vismodegib—Decreased appetite—Lamotrigine—epilepsy syndrome	0.000117	0.00108	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000116	0.00108	CcSEcCtD
Vismodegib—Abdominal pain—Clonazepam—epilepsy syndrome	0.000116	0.00108	CcSEcCtD
Vismodegib—Fatigue—Lamotrigine—epilepsy syndrome	0.000116	0.00107	CcSEcCtD
Vismodegib—Dysgeusia—Pregabalin—epilepsy syndrome	0.000116	0.00107	CcSEcCtD
Vismodegib—Pruritus—Vigabatrin—epilepsy syndrome	0.000116	0.00107	CcSEcCtD
Vismodegib—Asthenia—Diazepam—epilepsy syndrome	0.000115	0.00107	CcSEcCtD
Vismodegib—Pain—Lamotrigine—epilepsy syndrome	0.000115	0.00107	CcSEcCtD
Vismodegib—Constipation—Lamotrigine—epilepsy syndrome	0.000115	0.00107	CcSEcCtD
Vismodegib—ABCB1—medulla oblongata—epilepsy syndrome	0.000115	0.00243	CbGeAlD
Vismodegib—Nausea—Acetazolamide—epilepsy syndrome	0.000115	0.00106	CcSEcCtD
Vismodegib—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000115	0.00106	CcSEcCtD
Vismodegib—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000115	0.00106	CcSEcCtD
Vismodegib—Back pain—Pregabalin—epilepsy syndrome	0.000115	0.00106	CcSEcCtD
Vismodegib—Vomiting—Propofol—epilepsy syndrome	0.000114	0.00106	CcSEcCtD
Vismodegib—Muscle spasms—Pregabalin—epilepsy syndrome	0.000114	0.00105	CcSEcCtD
Vismodegib—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000114	0.00105	CcSEcCtD
Vismodegib—Pruritus—Diazepam—epilepsy syndrome	0.000114	0.00105	CcSEcCtD
Vismodegib—Rash—Propofol—epilepsy syndrome	0.000113	0.00105	CcSEcCtD
Vismodegib—Dermatitis—Propofol—epilepsy syndrome	0.000113	0.00105	CcSEcCtD
Vismodegib—Vomiting—Midazolam—epilepsy syndrome	0.000112	0.00104	CcSEcCtD
Vismodegib—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000112	0.00104	CcSEcCtD
Vismodegib—Asthenia—Felbamate—epilepsy syndrome	0.000112	0.00103	CcSEcCtD
Vismodegib—Myalgia—Valproic Acid—epilepsy syndrome	0.000112	0.00103	CcSEcCtD
Vismodegib—Arthralgia—Valproic Acid—epilepsy syndrome	0.000112	0.00103	CcSEcCtD
Vismodegib—Rash—Midazolam—epilepsy syndrome	0.000111	0.00103	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000111	0.00103	CcSEcCtD
Vismodegib—Dermatitis—Midazolam—epilepsy syndrome	0.000111	0.00103	CcSEcCtD
Vismodegib—Vomiting—Levetiracetam—epilepsy syndrome	0.00011	0.00102	CcSEcCtD
Vismodegib—Sorafenib—CYP2D6—epilepsy syndrome	0.00011	0.0352	CrCbGaD
Vismodegib—Alopecia—Gabapentin—epilepsy syndrome	0.00011	0.00102	CcSEcCtD
Vismodegib—Pruritus—Felbamate—epilepsy syndrome	0.00011	0.00102	CcSEcCtD
Vismodegib—Abdominal pain—Carbamazepine—epilepsy syndrome	0.00011	0.00102	CcSEcCtD
Vismodegib—Diarrhoea—Diazepam—epilepsy syndrome	0.00011	0.00102	CcSEcCtD
Vismodegib—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.00011	0.00102	CcSEcCtD
Vismodegib—Rash—Levetiracetam—epilepsy syndrome	0.00011	0.00101	CcSEcCtD
Vismodegib—Dermatitis—Levetiracetam—epilepsy syndrome	0.000109	0.00101	CcSEcCtD
Vismodegib—Asthenia—Zonisamide—epilepsy syndrome	0.000109	0.00101	CcSEcCtD
Vismodegib—Malnutrition—Gabapentin—epilepsy syndrome	0.000109	0.00101	CcSEcCtD
Vismodegib—Pruritus—Zonisamide—epilepsy syndrome	0.000108	0.000998	CcSEcCtD
Vismodegib—Nausea—Propofol—epilepsy syndrome	0.000107	0.000989	CcSEcCtD
Vismodegib—Vomiting—Fosphenytoin—epilepsy syndrome	0.000107	0.000987	CcSEcCtD
Vismodegib—Diarrhoea—Felbamate—epilepsy syndrome	0.000107	0.000986	CcSEcCtD
Vismodegib—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000106	0.000985	CcSEcCtD
Vismodegib—Dysgeusia—Gabapentin—epilepsy syndrome	0.000106	0.000985	CcSEcCtD
Vismodegib—Rash—Fosphenytoin—epilepsy syndrome	0.000106	0.000979	CcSEcCtD
Vismodegib—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000106	0.000978	CcSEcCtD
Vismodegib—Asthenia—Clonazepam—epilepsy syndrome	0.000105	0.000976	CcSEcCtD
Vismodegib—ABCB1—midbrain—epilepsy syndrome	0.000105	0.00222	CbGeAlD
Vismodegib—Back pain—Gabapentin—epilepsy syndrome	0.000105	0.000973	CcSEcCtD
Vismodegib—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000105	0.000971	CcSEcCtD
Vismodegib—Asthenia—Phenytoin—epilepsy syndrome	0.000105	0.000969	CcSEcCtD
Vismodegib—Nausea—Midazolam—epilepsy syndrome	0.000105	0.000967	CcSEcCtD
Vismodegib—Muscle spasms—Gabapentin—epilepsy syndrome	0.000104	0.000967	CcSEcCtD
Vismodegib—Diarrhoea—Zonisamide—epilepsy syndrome	0.000104	0.000965	CcSEcCtD
Vismodegib—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000104	0.000964	CcSEcCtD
Vismodegib—Pruritus—Clonazepam—epilepsy syndrome	0.000104	0.000962	CcSEcCtD
Vismodegib—Vomiting—Vigabatrin—epilepsy syndrome	0.000104	0.000962	CcSEcCtD
Vismodegib—Skin disorder—Valproic Acid—epilepsy syndrome	0.000104	0.000962	CcSEcCtD
Vismodegib—Pruritus—Phenytoin—epilepsy syndrome	0.000103	0.000956	CcSEcCtD
Vismodegib—Connective tissue disorder—Topiramate—epilepsy syndrome	0.000103	0.000955	CcSEcCtD
Vismodegib—Nausea—Levetiracetam—epilepsy syndrome	0.000103	0.000955	CcSEcCtD
Vismodegib—Rash—Vigabatrin—epilepsy syndrome	0.000103	0.000954	CcSEcCtD
Vismodegib—Dermatitis—Vigabatrin—epilepsy syndrome	0.000103	0.000953	CcSEcCtD
Vismodegib—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000103	0.000951	CcSEcCtD
Vismodegib—ABCB1—spinal cord—epilepsy syndrome	0.000103	0.00217	CbGeAlD
Vismodegib—Vomiting—Diazepam—epilepsy syndrome	0.000102	0.000947	CcSEcCtD
Vismodegib—Rash—Diazepam—epilepsy syndrome	0.000101	0.000939	CcSEcCtD
Vismodegib—Dermatitis—Diazepam—epilepsy syndrome	0.000101	0.000938	CcSEcCtD
Vismodegib—Arthralgia—Pregabalin—epilepsy syndrome	0.000101	0.000934	CcSEcCtD
Vismodegib—Myalgia—Pregabalin—epilepsy syndrome	0.000101	0.000934	CcSEcCtD
Vismodegib—Diarrhoea—Clonazepam—epilepsy syndrome	0.000101	0.00093	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.0001	0.000927	CcSEcCtD
Vismodegib—Asthenia—Carbamazepine—epilepsy syndrome	0.0001	0.000925	CcSEcCtD
Vismodegib—Diarrhoea—Phenytoin—epilepsy syndrome	9.99e-05	0.000924	CcSEcCtD
Vismodegib—Nausea—Fosphenytoin—epilepsy syndrome	9.96e-05	0.000922	CcSEcCtD
Vismodegib—Diarrhoea—Oxcarbazepine—epilepsy syndrome	9.93e-05	0.000919	CcSEcCtD
Vismodegib—Vomiting—Felbamate—epilepsy syndrome	9.9e-05	0.000917	CcSEcCtD
Vismodegib—Pruritus—Carbamazepine—epilepsy syndrome	9.86e-05	0.000912	CcSEcCtD
Vismodegib—Sulfasalazine—PTGS2—epilepsy syndrome	9.82e-05	0.0313	CrCbGaD
Vismodegib—Rash—Felbamate—epilepsy syndrome	9.82e-05	0.000909	CcSEcCtD
Vismodegib—Dermatitis—Felbamate—epilepsy syndrome	9.81e-05	0.000908	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	9.75e-05	0.000902	CcSEcCtD
Vismodegib—Nausea—Vigabatrin—epilepsy syndrome	9.71e-05	0.000899	CcSEcCtD
Vismodegib—Vomiting—Zonisamide—epilepsy syndrome	9.69e-05	0.000897	CcSEcCtD
Vismodegib—Asthenia—Lamotrigine—epilepsy syndrome	9.66e-05	0.000894	CcSEcCtD
Vismodegib—Rash—Zonisamide—epilepsy syndrome	9.61e-05	0.00089	CcSEcCtD
Vismodegib—Dermatitis—Zonisamide—epilepsy syndrome	9.6e-05	0.000889	CcSEcCtD
Vismodegib—Nausea—Diazepam—epilepsy syndrome	9.56e-05	0.000885	CcSEcCtD
Vismodegib—Diarrhoea—Carbamazepine—epilepsy syndrome	9.53e-05	0.000882	CcSEcCtD
Vismodegib—Pruritus—Lamotrigine—epilepsy syndrome	9.53e-05	0.000882	CcSEcCtD
Vismodegib—Nervous system disorder—Pregabalin—epilepsy syndrome	9.49e-05	0.000878	CcSEcCtD
Vismodegib—Dyspepsia—Valproic Acid—epilepsy syndrome	9.42e-05	0.000872	CcSEcCtD
Vismodegib—Skin disorder—Pregabalin—epilepsy syndrome	9.4e-05	0.00087	CcSEcCtD
Vismodegib—Vomiting—Clonazepam—epilepsy syndrome	9.34e-05	0.000865	CcSEcCtD
Vismodegib—Decreased appetite—Valproic Acid—epilepsy syndrome	9.3e-05	0.000861	CcSEcCtD
Vismodegib—Alopecia—Topiramate—epilepsy syndrome	9.28e-05	0.000859	CcSEcCtD
Vismodegib—Vomiting—Phenytoin—epilepsy syndrome	9.28e-05	0.000859	CcSEcCtD
Vismodegib—Rash—Clonazepam—epilepsy syndrome	9.26e-05	0.000857	CcSEcCtD
Vismodegib—Dermatitis—Clonazepam—epilepsy syndrome	9.26e-05	0.000857	CcSEcCtD
Vismodegib—Myalgia—Gabapentin—epilepsy syndrome	9.25e-05	0.000856	CcSEcCtD
Vismodegib—Arthralgia—Gabapentin—epilepsy syndrome	9.25e-05	0.000856	CcSEcCtD
Vismodegib—Nausea—Felbamate—epilepsy syndrome	9.25e-05	0.000856	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	9.24e-05	0.000855	CcSEcCtD
Vismodegib—Vomiting—Oxcarbazepine—epilepsy syndrome	9.23e-05	0.000854	CcSEcCtD
Vismodegib—Fatigue—Valproic Acid—epilepsy syndrome	9.22e-05	0.000854	CcSEcCtD
Vismodegib—Diarrhoea—Lamotrigine—epilepsy syndrome	9.21e-05	0.000853	CcSEcCtD
Vismodegib—Rash—Phenytoin—epilepsy syndrome	9.2e-05	0.000852	CcSEcCtD
Vismodegib—Dermatitis—Phenytoin—epilepsy syndrome	9.19e-05	0.000851	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	9.19e-05	0.00085	CcSEcCtD
Vismodegib—Rash—Oxcarbazepine—epilepsy syndrome	9.15e-05	0.000847	CcSEcCtD
Vismodegib—Pain—Valproic Acid—epilepsy syndrome	9.15e-05	0.000847	CcSEcCtD
Vismodegib—Constipation—Valproic Acid—epilepsy syndrome	9.15e-05	0.000847	CcSEcCtD
Vismodegib—Dermatitis—Oxcarbazepine—epilepsy syndrome	9.15e-05	0.000846	CcSEcCtD
Vismodegib—Malnutrition—Topiramate—epilepsy syndrome	9.14e-05	0.000846	CcSEcCtD
Vismodegib—ABCB1—head—epilepsy syndrome	9.12e-05	0.00193	CbGeAlD
Vismodegib—Nausea—Zonisamide—epilepsy syndrome	9.06e-05	0.000838	CcSEcCtD
Vismodegib—Dysgeusia—Topiramate—epilepsy syndrome	8.95e-05	0.000829	CcSEcCtD
Vismodegib—Vomiting—Carbamazepine—epilepsy syndrome	8.86e-05	0.00082	CcSEcCtD
Vismodegib—Back pain—Topiramate—epilepsy syndrome	8.84e-05	0.000819	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	8.81e-05	0.000816	CcSEcCtD
Vismodegib—Muscle spasms—Topiramate—epilepsy syndrome	8.79e-05	0.000814	CcSEcCtD
Vismodegib—Rash—Carbamazepine—epilepsy syndrome	8.78e-05	0.000813	CcSEcCtD
Vismodegib—Dermatitis—Carbamazepine—epilepsy syndrome	8.78e-05	0.000812	CcSEcCtD
Vismodegib—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	8.75e-05	0.00081	CcSEcCtD
Vismodegib—Nausea—Clonazepam—epilepsy syndrome	8.73e-05	0.000808	CcSEcCtD
Vismodegib—Nervous system disorder—Gabapentin—epilepsy syndrome	8.7e-05	0.000805	CcSEcCtD
Vismodegib—Nausea—Phenytoin—epilepsy syndrome	8.67e-05	0.000802	CcSEcCtD
Vismodegib—ABCB1—nervous system—epilepsy syndrome	8.65e-05	0.00183	CbGeAlD
Vismodegib—Nausea—Oxcarbazepine—epilepsy syndrome	8.62e-05	0.000798	CcSEcCtD
Vismodegib—Skin disorder—Gabapentin—epilepsy syndrome	8.62e-05	0.000797	CcSEcCtD
Vismodegib—Vomiting—Lamotrigine—epilepsy syndrome	8.56e-05	0.000792	CcSEcCtD
Vismodegib—Rash—Lamotrigine—epilepsy syndrome	8.49e-05	0.000786	CcSEcCtD
Vismodegib—Dermatitis—Lamotrigine—epilepsy syndrome	8.48e-05	0.000785	CcSEcCtD
Vismodegib—Abdominal pain—Valproic Acid—epilepsy syndrome	8.46e-05	0.000783	CcSEcCtD
Vismodegib—Decreased appetite—Pregabalin—epilepsy syndrome	8.41e-05	0.000778	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	8.35e-05	0.000773	CcSEcCtD
Vismodegib—Fatigue—Pregabalin—epilepsy syndrome	8.34e-05	0.000772	CcSEcCtD
Vismodegib—ABCB1—central nervous system—epilepsy syndrome	8.33e-05	0.00176	CbGeAlD
Vismodegib—Nausea—Carbamazepine—epilepsy syndrome	8.28e-05	0.000766	CcSEcCtD
Vismodegib—Pain—Pregabalin—epilepsy syndrome	8.27e-05	0.000766	CcSEcCtD
Vismodegib—Constipation—Pregabalin—epilepsy syndrome	8.27e-05	0.000766	CcSEcCtD
Vismodegib—ABCB1—cerebellum—epilepsy syndrome	8.14e-05	0.00172	CbGeAlD
Vismodegib—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	8.08e-05	0.000748	CcSEcCtD
Vismodegib—Nausea—Lamotrigine—epilepsy syndrome	8e-05	0.00074	CcSEcCtD
Vismodegib—Gastrointestinal pain—Pregabalin—epilepsy syndrome	7.91e-05	0.000732	CcSEcCtD
Vismodegib—Sorafenib—ABCB1—epilepsy syndrome	7.88e-05	0.0251	CrCbGaD
Vismodegib—Dyspepsia—Gabapentin—epilepsy syndrome	7.81e-05	0.000723	CcSEcCtD
Vismodegib—Arthralgia—Topiramate—epilepsy syndrome	7.78e-05	0.00072	CcSEcCtD
Vismodegib—Myalgia—Topiramate—epilepsy syndrome	7.78e-05	0.00072	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	7.73e-05	0.000715	CcSEcCtD
Vismodegib—Decreased appetite—Gabapentin—epilepsy syndrome	7.71e-05	0.000714	CcSEcCtD
Vismodegib—Asthenia—Valproic Acid—epilepsy syndrome	7.68e-05	0.00071	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	7.66e-05	0.000709	CcSEcCtD
Vismodegib—Fatigue—Gabapentin—epilepsy syndrome	7.65e-05	0.000708	CcSEcCtD
Vismodegib—Abdominal pain—Pregabalin—epilepsy syndrome	7.65e-05	0.000708	CcSEcCtD
Vismodegib—Pain—Gabapentin—epilepsy syndrome	7.59e-05	0.000702	CcSEcCtD
Vismodegib—Constipation—Gabapentin—epilepsy syndrome	7.59e-05	0.000702	CcSEcCtD
Vismodegib—Pruritus—Valproic Acid—epilepsy syndrome	7.57e-05	0.000701	CcSEcCtD
Vismodegib—Diarrhoea—Valproic Acid—epilepsy syndrome	7.32e-05	0.000678	CcSEcCtD
Vismodegib—Nervous system disorder—Topiramate—epilepsy syndrome	7.32e-05	0.000677	CcSEcCtD
Vismodegib—Gastrointestinal pain—Gabapentin—epilepsy syndrome	7.25e-05	0.000671	CcSEcCtD
Vismodegib—Skin disorder—Topiramate—epilepsy syndrome	7.25e-05	0.000671	CcSEcCtD
Vismodegib—Abdominal pain—Gabapentin—epilepsy syndrome	7.01e-05	0.000649	CcSEcCtD
Vismodegib—Asthenia—Pregabalin—epilepsy syndrome	6.94e-05	0.000642	CcSEcCtD
Vismodegib—Pruritus—Pregabalin—epilepsy syndrome	6.84e-05	0.000633	CcSEcCtD
Vismodegib—Vomiting—Valproic Acid—epilepsy syndrome	6.8e-05	0.00063	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	6.8e-05	0.000629	CcSEcCtD
Vismodegib—Rash—Valproic Acid—epilepsy syndrome	6.75e-05	0.000624	CcSEcCtD
Vismodegib—Dermatitis—Valproic Acid—epilepsy syndrome	6.74e-05	0.000624	CcSEcCtD
Vismodegib—Diarrhoea—Pregabalin—epilepsy syndrome	6.62e-05	0.000613	CcSEcCtD
Vismodegib—ABCB1—brain—epilepsy syndrome	6.61e-05	0.0014	CbGeAlD
Vismodegib—Dyspepsia—Topiramate—epilepsy syndrome	6.57e-05	0.000608	CcSEcCtD
Vismodegib—Decreased appetite—Topiramate—epilepsy syndrome	6.49e-05	0.0006	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Topiramate—epilepsy syndrome	6.44e-05	0.000596	CcSEcCtD
Vismodegib—Fatigue—Topiramate—epilepsy syndrome	6.43e-05	0.000595	CcSEcCtD
Vismodegib—Pain—Topiramate—epilepsy syndrome	6.38e-05	0.000591	CcSEcCtD
Vismodegib—Constipation—Topiramate—epilepsy syndrome	6.38e-05	0.000591	CcSEcCtD
Vismodegib—Asthenia—Gabapentin—epilepsy syndrome	6.36e-05	0.000589	CcSEcCtD
Vismodegib—Nausea—Valproic Acid—epilepsy syndrome	6.36e-05	0.000588	CcSEcCtD
Vismodegib—Pruritus—Gabapentin—epilepsy syndrome	6.28e-05	0.000581	CcSEcCtD
Vismodegib—Vomiting—Pregabalin—epilepsy syndrome	6.15e-05	0.000569	CcSEcCtD
Vismodegib—Gastrointestinal pain—Topiramate—epilepsy syndrome	6.1e-05	0.000565	CcSEcCtD
Vismodegib—Rash—Pregabalin—epilepsy syndrome	6.1e-05	0.000564	CcSEcCtD
Vismodegib—Dermatitis—Pregabalin—epilepsy syndrome	6.09e-05	0.000564	CcSEcCtD
Vismodegib—Diarrhoea—Gabapentin—epilepsy syndrome	6.07e-05	0.000562	CcSEcCtD
Vismodegib—Abdominal pain—Topiramate—epilepsy syndrome	5.9e-05	0.000546	CcSEcCtD
Vismodegib—Nausea—Pregabalin—epilepsy syndrome	5.75e-05	0.000532	CcSEcCtD
Vismodegib—Vomiting—Gabapentin—epilepsy syndrome	5.64e-05	0.000522	CcSEcCtD
Vismodegib—Rash—Gabapentin—epilepsy syndrome	5.59e-05	0.000518	CcSEcCtD
Vismodegib—Dermatitis—Gabapentin—epilepsy syndrome	5.59e-05	0.000517	CcSEcCtD
Vismodegib—Asthenia—Topiramate—epilepsy syndrome	5.35e-05	0.000496	CcSEcCtD
Vismodegib—Pruritus—Topiramate—epilepsy syndrome	5.28e-05	0.000489	CcSEcCtD
Vismodegib—Nausea—Gabapentin—epilepsy syndrome	5.27e-05	0.000488	CcSEcCtD
Vismodegib—Diarrhoea—Topiramate—epilepsy syndrome	5.11e-05	0.000473	CcSEcCtD
Vismodegib—Vomiting—Topiramate—epilepsy syndrome	4.74e-05	0.000439	CcSEcCtD
Vismodegib—Rash—Topiramate—epilepsy syndrome	4.71e-05	0.000435	CcSEcCtD
Vismodegib—Dermatitis—Topiramate—epilepsy syndrome	4.7e-05	0.000435	CcSEcCtD
Vismodegib—Nausea—Topiramate—epilepsy syndrome	4.43e-05	0.00041	CcSEcCtD
Vismodegib—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	6.22e-06	8.71e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	6.22e-06	8.71e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PNPO—epilepsy syndrome	6.22e-06	8.71e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GAMT—epilepsy syndrome	6.22e-06	8.71e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ALDH7A1—epilepsy syndrome	6.19e-06	8.68e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CACNA1A—epilepsy syndrome	6.19e-06	8.68e-05	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—VEGFA—epilepsy syndrome	6.19e-06	8.68e-05	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	6.18e-06	8.67e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	6.07e-06	8.51e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ST3GAL3—epilepsy syndrome	6.06e-06	8.49e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	6.04e-06	8.47e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	6.04e-06	8.47e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CYP2D6—epilepsy syndrome	6.04e-06	8.46e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—TXNRD1—epilepsy syndrome	5.99e-06	8.39e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—YWHAZ—epilepsy syndrome	5.99e-06	8.39e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—TXNRD1—epilepsy syndrome	5.95e-06	8.35e-05	CbGpPWpGaD
Vismodegib—SHH—Disease—AKT1—epilepsy syndrome	5.95e-06	8.34e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ADSL—epilepsy syndrome	5.94e-06	8.32e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ALAD—epilepsy syndrome	5.92e-06	8.3e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—NT5E—epilepsy syndrome	5.92e-06	8.3e-05	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	5.92e-06	8.29e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	5.91e-06	8.29e-05	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—AVP—epilepsy syndrome	5.86e-06	8.22e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GLUL—epilepsy syndrome	5.82e-06	8.16e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—AQP1—epilepsy syndrome	5.81e-06	8.15e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ADSL—epilepsy syndrome	5.79e-06	8.12e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—AQP1—epilepsy syndrome	5.78e-06	8.1e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CA4—epilepsy syndrome	5.78e-06	8.1e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—QDPR—epilepsy syndrome	5.78e-06	8.1e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	5.76e-06	8.07e-05	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	5.76e-06	8.07e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ADRA2A—epilepsy syndrome	5.75e-06	8.06e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—BCHE—epilepsy syndrome	5.72e-06	8.02e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	5.71e-06	8.01e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GLUL—epilepsy syndrome	5.68e-06	7.97e-05	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	5.68e-06	7.96e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	5.65e-06	7.91e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	5.65e-06	7.91e-05	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	5.63e-06	7.9e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.58e-06	7.83e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	5.58e-06	7.82e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.55e-06	7.78e-05	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	5.55e-06	7.77e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	5.53e-06	7.75e-05	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	5.49e-06	7.69e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—SLC2A1—epilepsy syndrome	5.46e-06	7.65e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—COX3—epilepsy syndrome	5.43e-06	7.62e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ADSL—epilepsy syndrome	5.41e-06	7.59e-05	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	5.4e-06	7.57e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PLCB1—epilepsy syndrome	5.4e-06	7.57e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—TH—epilepsy syndrome	5.38e-06	7.54e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	5.35e-06	7.49e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—PLAU—epilepsy syndrome	5.31e-06	7.45e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GLUL—epilepsy syndrome	5.31e-06	7.44e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	5.26e-06	7.37e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	5.26e-06	7.37e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CHRM3—epilepsy syndrome	5.23e-06	7.33e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—KCNJ11—epilepsy syndrome	5.23e-06	7.33e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	5.22e-06	7.31e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	5.21e-06	7.3e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—AQP1—epilepsy syndrome	5.19e-06	7.27e-05	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	5.18e-06	7.27e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	5.15e-06	7.22e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	5.15e-06	7.22e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	5.15e-06	7.22e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PFKL—epilepsy syndrome	5.15e-06	7.22e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	5.15e-06	7.22e-05	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	5.14e-06	7.2e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—AQP1—epilepsy syndrome	5.06e-06	7.1e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.98e-06	6.99e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—PRKCB—epilepsy syndrome	4.94e-06	6.93e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.9e-06	6.86e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—NOS2—epilepsy syndrome	4.88e-06	6.84e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	4.87e-06	6.83e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.87e-06	6.82e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.8e-06	6.72e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.77e-06	6.69e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—AQP1—epilepsy syndrome	4.73e-06	6.63e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—NEU1—epilepsy syndrome	4.71e-06	6.6e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—UPB1—epilepsy syndrome	4.71e-06	6.6e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ATIC—epilepsy syndrome	4.71e-06	6.6e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	4.69e-06	6.58e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	4.69e-06	6.58e-05	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	4.63e-06	6.49e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CHRM3—epilepsy syndrome	4.58e-06	6.42e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	4.58e-06	6.42e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.54e-06	6.37e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	4.53e-06	6.36e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—HMOX1—epilepsy syndrome	4.49e-06	6.29e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CAT—epilepsy syndrome	4.43e-06	6.21e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	4.38e-06	6.14e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GBE1—epilepsy syndrome	4.38e-06	6.14e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.37e-06	6.13e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ABCB1—epilepsy syndrome	4.31e-06	6.04e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	4.29e-06	6.01e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.28e-06	6e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	4.28e-06	6e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	4.28e-06	6e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ABCG2—epilepsy syndrome	4.26e-06	5.97e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	4.18e-06	5.85e-05	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—AKT1—epilepsy syndrome	4.17e-06	5.84e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CYP2C19—epilepsy syndrome	4.15e-06	5.82e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	4.15e-06	5.82e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CYP11A1—epilepsy syndrome	4.13e-06	5.79e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.12e-06	5.78e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	4.12e-06	5.77e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.1e-06	5.74e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GPX1—epilepsy syndrome	4.01e-06	5.62e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	4.01e-06	5.61e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.98e-06	5.59e-05	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—AKT1—epilepsy syndrome	3.95e-06	5.54e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.9e-06	5.47e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—NT5E—epilepsy syndrome	3.9e-06	5.47e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ALAD—epilepsy syndrome	3.9e-06	5.47e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	3.83e-06	5.36e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.76e-06	5.27e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	3.75e-06	5.25e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ABCG2—epilepsy syndrome	3.73e-06	5.23e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CYP2D6—epilepsy syndrome	3.72e-06	5.22e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	3.72e-06	5.22e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	3.72e-06	5.22e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	3.7e-06	5.19e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.68e-06	5.16e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	3.64e-06	5.11e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	3.64e-06	5.1e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	3.62e-06	5.07e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ADSL—epilepsy syndrome	3.57e-06	5e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	3.57e-06	5e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—BCHE—epilepsy syndrome	3.55e-06	4.98e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ADRA2A—epilepsy syndrome	3.55e-06	4.97e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—BCHE—epilepsy syndrome	3.53e-06	4.95e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—AGT—epilepsy syndrome	3.51e-06	4.93e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GLUL—epilepsy syndrome	3.5e-06	4.91e-05	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	3.5e-06	4.91e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	3.49e-06	4.89e-05	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	3.45e-06	4.83e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—APOE—epilepsy syndrome	3.44e-06	4.83e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	3.44e-06	4.82e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	3.4e-06	4.76e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	3.39e-06	4.75e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	3.38e-06	4.74e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—SLC2A1—epilepsy syndrome	3.37e-06	4.72e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.35e-06	4.7e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.35e-06	4.7e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	3.35e-06	4.7e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	3.34e-06	4.69e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—TH—epilepsy syndrome	3.34e-06	4.68e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PLCB1—epilepsy syndrome	3.33e-06	4.67e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—TH—epilepsy syndrome	3.32e-06	4.65e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.29e-06	4.61e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.27e-06	4.58e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	3.26e-06	4.57e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	3.21e-06	4.51e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	3.18e-06	4.46e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—BCHE—epilepsy syndrome	3.17e-06	4.44e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.12e-06	4.37e-05	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.11e-06	4.36e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	3.11e-06	4.36e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—BCHE—epilepsy syndrome	3.09e-06	4.34e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.06e-06	4.29e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	3.05e-06	4.27e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	3.02e-06	4.24e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	2.99e-06	4.19e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—TH—epilepsy syndrome	2.98e-06	4.18e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—POMC—epilepsy syndrome	2.96e-06	4.15e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	2.95e-06	4.14e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.93e-06	4.11e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PLCB1—epilepsy syndrome	2.92e-06	4.09e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—TH—epilepsy syndrome	2.91e-06	4.08e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—SRC—epilepsy syndrome	2.9e-06	4.07e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	2.9e-06	4.07e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—BCHE—epilepsy syndrome	2.89e-06	4.05e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—VEGFA—epilepsy syndrome	2.83e-06	3.96e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.82e-06	3.96e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.82e-06	3.96e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	2.79e-06	3.91e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—HMOX1—epilepsy syndrome	2.77e-06	3.88e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	2.76e-06	3.87e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CAT—epilepsy syndrome	2.75e-06	3.85e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CAT—epilepsy syndrome	2.73e-06	3.83e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	2.73e-06	3.82e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—TH—epilepsy syndrome	2.72e-06	3.81e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ALB—epilepsy syndrome	2.7e-06	3.78e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.68e-06	3.75e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	2.67e-06	3.75e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ABCB1—epilepsy syndrome	2.66e-06	3.73e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	2.49e-06	3.49e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GPX1—epilepsy syndrome	2.49e-06	3.49e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GPX1—epilepsy syndrome	2.47e-06	3.47e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CAT—epilepsy syndrome	2.45e-06	3.44e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—HMOX1—epilepsy syndrome	2.43e-06	3.4e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CAT—epilepsy syndrome	2.4e-06	3.36e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	2.39e-06	3.35e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PTGS2—epilepsy syndrome	2.36e-06	3.31e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.3e-06	3.22e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	2.27e-06	3.18e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.24e-06	3.14e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CAT—epilepsy syndrome	2.24e-06	3.14e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.23e-06	3.12e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GPX1—epilepsy syndrome	2.22e-06	3.11e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—AGT—epilepsy syndrome	2.18e-06	3.06e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	2.18e-06	3.05e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—AGT—epilepsy syndrome	2.17e-06	3.04e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GPX1—epilepsy syndrome	2.17e-06	3.04e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—APOE—epilepsy syndrome	2.14e-06	2.99e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—APOE—epilepsy syndrome	2.12e-06	2.98e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GPX1—epilepsy syndrome	2.02e-06	2.84e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.01e-06	2.82e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—AGT—epilepsy syndrome	1.95e-06	2.73e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.91e-06	2.68e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—APOE—epilepsy syndrome	1.91e-06	2.67e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.91e-06	2.67e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—AGT—epilepsy syndrome	1.9e-06	2.66e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—APOE—epilepsy syndrome	1.86e-06	2.61e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—POMC—epilepsy syndrome	1.84e-06	2.57e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—POMC—epilepsy syndrome	1.82e-06	2.56e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.82e-06	2.55e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—AKT1—epilepsy syndrome	1.8e-06	2.53e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.8e-06	2.52e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—TH—epilepsy syndrome	1.79e-06	2.51e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.77e-06	2.49e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.74e-06	2.44e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ALB—epilepsy syndrome	1.67e-06	2.35e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—POMC—epilepsy syndrome	1.64e-06	2.3e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—POMC—epilepsy syndrome	1.6e-06	2.24e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.5e-06	2.1e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.49e-06	2.09e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.49e-06	2.09e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.48e-06	2.07e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	1.46e-06	2.05e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ALB—epilepsy syndrome	1.46e-06	2.04e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PTGS2—epilepsy syndrome	1.46e-06	2.04e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.44e-06	2.01e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.36e-06	1.91e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.33e-06	1.87e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.31e-06	1.83e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.28e-06	1.79e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.19e-06	1.67e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—AKT1—epilepsy syndrome	1.19e-06	1.66e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.17e-06	1.64e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.15e-06	1.61e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—POMC—epilepsy syndrome	9.85e-07	1.38e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ALB—epilepsy syndrome	8.98e-07	1.26e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	7.86e-07	1.1e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—AKT1—epilepsy syndrome	7.36e-07	1.03e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—AKT1—epilepsy syndrome	7.32e-07	1.03e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—AKT1—epilepsy syndrome	6.57e-07	9.21e-06	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—AKT1—epilepsy syndrome	6.41e-07	8.98e-06	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—AKT1—epilepsy syndrome	5.99e-07	8.39e-06	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—AKT1—epilepsy syndrome	3.95e-07	5.54e-06	CbGpPWpGaD
